Muscle-invasive Bladder Cancer

DBCOND0042339NeoplasmsUrogenital Diseases

Muscle-invasive Bladder Cancer is the indication for 4 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
Muscle Invasive Bladder Cancer · Carcinoma of Urinary Bladder, Invasive · Invasive Bladder Cancer · Muscle Invasive Bladder Carcinoma · Muscle-invasive Urothelial Cancer of the Bladder
Classified under
Indicated drugs

Resolves to

Vocabularies
ICD-10C67SNOMED CT188248005MedDRA10005013UMLSC0005684

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
112Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Muscle-invasive Bladder Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In